SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roger Cranwill who wrote (1304)10/11/1997 1:00:00 PM
From: contrarian   of 1762
 
Roger,

Capitalism is a great thing. I only wish our goverment would lower taxes and eliminate regulation. It is amazing what is being done in spite not because of the goverment.

IDEC continues to exhibit a classical staircase rise. Last weeks highs are now this weeks lows. The stocks RPS continues to make new highs under heavy accumulation. We also have the biotech driven small cap rally underway. The only thing we have to fear is Alan Greenspan.
The good news is that small stocks do better when interest rates are rising. I personally think that this is the last up swing in interest rates before the next big drive to below 6.0%. This would be a positive for all stocks including IDEC. Either way 98 looks like a great year for our relatively unknown IDPH.

Since I am not that familar with this industry can you explain how important IDEC's new drug is on the tumor fighting front? I know it is a breakthrough but how does it measure up to other biotech milestones?

Thanks for Inputs,

Contrarian
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News